|
|
 | | | |
- close
- close
- close
- close
Sangamo BioSciences (SGMO) |
Benzinga
May 24
Comment
Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million Strategic Partnership Award to develop a potentially curative ZFP Therapeutic for...
Benzinga
May 15
Comment
Sangamo BioSciences, Inc.
(Nasdaq: SGMO) announced today the presentation of new clinical data from its
program to develop a ZFP Therapeutic^® for HIV/AIDS. The data,
which demonstrate that SB-728-T treatment results in a reduction in the...
Benzinga
Mar 7
Comment
Wedbush maintained Sangamo BioSciences (NASDAQ: SGMO) with an Outperform rating and raised the price target from $10.00 to $13.00.
Wedbush said, "Sangamo presented immunologic results supporting previous observations about the functionality and...
TheStreet.com
Mar 6
Comment
RICHMOND, Calif. (TheStreet) -- Sangamo BioSciences is a gene therapy company with a single product in human clinical studies and a market value of more than $500 million. The rest of the company's pipeline is still preclinical, meaning the only...
Benzinga
Feb 19
Comment
Burrill initiated coverage on Sangamo Biosciences (NASDAQ: SGMO) with a Market Outperform rating and a $28.00 price target.
Burrill noted, "We believe Sangamo's innovative genome editing approach could provide novel and transformative...
StreetInsider.com
Feb 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Sangamo+Biosciences%2C+Inc.+%28SGMO%29+Tops+Q4+EPS+by+5c%2C+Guides+FY+Rev/8066190.html for the full story.
Benzinga
Jan 10
Comment
Ryanair Holdings plc (NASDAQ: RYAAY) shares gained 2.23% to create a new 52-week high of $38.28. Ryanair Holdings' PEG ratio is 1.25.
News Corp (NASDAQ: NWSA) shares jumped 1.77% to create a new 52-week high of $26.86. News Corp's...
StreetInsider.com
Oct 24
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Sangamo+Biosciences%2C+Inc.+%28SGMO%29+Tops+Q3+EPS+by+3c/7816344.html for the full story.
StreetInsider.com
Sep 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sangamo+Bio+%28SGMO%29+Reports+Statistically+Significant+CD4+Improvement+in+SB-728-T+Phase+1+on+HAART/7715061.html for the full story.
StreetInsider.com
Jul 25
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Sangamo+Biosciences%2C+Inc.+%28SGMO%29+Tops+Q2+EPS+by+3c/7604675.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
